Shamiyeh E - Search Results

1

IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.

Perlman H, Bradley K, Liu H, Cole S, Shamiyeh E, Smith RC, Walsh K, Fiore S, Koch AE, Firestein GS, Haines GK 3rd, Pope RM. Perlman H, et al. Among authors: shamiyeh e. J Immunol. 2003 Jan 15;170(2):838-45. doi: 10.4049/jimmunol.170.2.838. J Immunol. 2003. PMID: 12517948

2

Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.

Bradley K, Scatizzi JC, Fiore S, Shamiyeh E, Koch AE, Firestein GS, Gorges LL, Kuntsman K, Pope RM, Moore TL, Han J, Perlman H. Bradley K, et al. Among authors: shamiyeh e. Arthritis Rheum. 2004 Jan;50(1):78-87. doi: 10.1002/art.11482. Arthritis Rheum. 2004. PMID: 14730602 Free article.

3

Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis.

Perlman H, Liu H, Georganas C, Koch AE, Shamiyeh E, Haines GK 3rd, Pope RM. Perlman H, et al. Among authors: shamiyeh e. Arthritis Rheum. 2001 Dec;44(12):2899-908. doi: 10.1002/1529-0131(200112)44:12<2899::aid-art478>3.0.co;2-x. Arthritis Rheum. 2001. PMID: 11762951 Free article.

4

History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, Dyer A, Curdy DM, Vogler L, Reed A, Cawkwell G, Zemel L, Sandborg C, Rivas-Chacon R, Hom C, Ilowite N, Gedalia A, Gitlin J, Borzy M. Pachman LM, et al. Among authors: shamiyeh e. Arthritis Rheum. 2005 Apr 15;53(2):166-72. doi: 10.1002/art.21068. Arthritis Rheum. 2005. PMID: 15818654 Free article.

5

The role of knee alignment in disease progression and functional decline in knee osteoarthritis.

Sharma L, Song J, Felson DT, Cahue S, Shamiyeh E, Dunlop DD. Sharma L, et al. Among authors: shamiyeh e. JAMA. 2001 Jul 11;286(2):188-95. doi: 10.1001/jama.286.2.188. JAMA. 2001. PMID: 11448282

6

Effect of food on the bioavailability and tolerability of the JAK2-selective inhibitor fedratinib (SAR302503): Results from two phase I studies in healthy volunteers.

Zhang M, Xu C, Ma L, Shamiyeh E, Yin J, von Moltke LL, Smith WB. Zhang M, et al. Among authors: shamiyeh e. Clin Pharmacol Drug Dev. 2015 Jul;4(4):315-21. doi: 10.1002/cpdd.161. Epub 2014 Oct 27. Clin Pharmacol Drug Dev. 2015. PMID: 27136912 Clinical Trial.

7

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.

Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL, Culm-Merdek K, Shamiyeh E, Inguilizian H, Cox GF, Puga AC. Wasserstein MP, et al. Among authors: shamiyeh e. Mol Genet Metab. 2015 Sep-Oct;116(1-2):88-97. doi: 10.1016/j.ymgme.2015.05.013. Epub 2015 May 30. Mol Genet Metab. 2015. PMID: 26049896 Free PMC article.

8

A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers.

Zhang M, Xu CR, Shamiyeh E, Liu F, Yin JY, von Moltke LL, Smith WB. Zhang M, et al. Among authors: shamiyeh e. J Clin Pharmacol. 2014 Apr;54(4):415-21. doi: 10.1002/jcph.218. Epub 2013 Nov 16. J Clin Pharmacol. 2014. PMID: 24165976 Clinical Trial.

9

Cortical bone thickness and bone mineral density.

Shamiyeh SG, Shamiyeh EG, Chhaya V. Shamiyeh SG, et al. Among authors: shamiyeh eg. J Clin Densitom. 2013 Jan-Mar;16(1):127-8. doi: 10.1016/j.jocd.2012.07.007. Epub 2012 Sep 12. J Clin Densitom. 2013. PMID: 22980489 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters